Rocket Pharmaceuticals (RCKT) Restructuring Costs (2025)
Rocket Pharmaceuticals' (RCKT) quarterly Restructuring Costs came in at -$68000.0 in Q4 2025, up 60.47% quarter-over-quarter from -$172000.0 in Q3 2025.
Rocket Pharmaceuticals (RCKT) Restructuring Costs (2025) Analysis & Trends
Rocket Pharmaceuticals has disclosed Restructuring Costs across 1 years of filings, most recently posting -$68000.0 for Q4 2025.
- Restructuring Costs for Q4 2025 came in at -$68000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.0 million (changed N/A YoY), and the FY2025 annual result was $3.2 million, changed N/A from the prior year.
- Restructuring Costs came in at -$68000.0 for Q4 2025 at Rocket Pharmaceuticals, up from -$172000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $3.2 million in Q2 2025 to a low of -$172000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Rocket Pharmaceuticals | 301.08 Mn | 301.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68,000.00 |
| Sep 30, 2025 | -172,000.00 |
| Jun 30, 2025 | 3.20 Mn |